• Benachenhou, N., Guiral, S., Gorska-Flipot, I., Labuda, D. & Sinnett, D. (1998) High resolution deletion mapping reveals frequent allelic losses at the DNA mismatch repair loci hMLH1 and hMSH3 in non-small cell lung cancer. International Journal of Cancer, 77, 173180.
  • Berwick, M. & Vineis, P. (2000) Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. Journal of the National Cancer Institute, 92, 874897.
  • Buermeyer, A.B., Deschenes, S.M., Baker, S.M. & Liskay, R.M. (1999) Mammalian DNA mismatch repair. Annual Review of Genetics, 33, 533564.
  • Eshleman, J.R. & Markowitz, S.D. (1996) Mismatch repair defects in human carcinogenesis. Human Molecular Genetics, 5, 14891494.
  • Hawn, M.T., Umar, A., Carethers, J.M., Marra, G., Kunkel, T.A., Boland, C.R. & Koi, M. (1995) Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. Cancer Research, 55, 37213725.
  • Hsieh, P. (2001) Molecular mechanisms of DNA mismatch repair. Mutation Research, 486, 7187.
  • Kat, A., Thilly, W.G., Fang, W.H., Longley, M.J., Li, G.M. & Modrich, P. (1993) An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proceedings of the National Academy of Sciences of the USA, 90, 64246428.
  • Kolodner, R. (1996) Biochemistry and genetics of eukaryotic mismatch repair. Genes and Development, 10, 14331442.
  • Krajinovic, M., Labuda, D., Richer, C., Karimi, S. & Sinnett, D. (1999) Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood, 93, 14961501.
  • Krajinovic, M., Richer, C., Sinnett, H., Labuda, D. & Sinnett, D. (2000) Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene–gene interaction in the susceptibility to childhood acute lymphoblastic leukemia. Cancer Epidemiology Biomarkers Prevention, 9, 557562.
  • Krajinovic, M., Sinnett, H., Richer, C., Labuda, D. & Sinnett, D. (2002) Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. International Journal of Cancer, 97, 230236.
  • Labuda, D., Krajinovic, M., Richer, C., Skoll, A., Sinnett, H., Yotova, V. & Sinnett, D. (1999) Rapid detection of CYP1A1, CYP2D6, and NAT variants by multiplex polymerase chain reaction and allele-specific oligonucleotide assay. Analytical Biochemistry, 275, 8492.
  • Mellon, I., Rajpal, D.K., Koi, M., Boland, C.R. & Champe, G.N. (1996) Transcription-coupled repair deficiency and mutations in human mismatch repair genes. Science, 272, 557560.
  • Miller, M.C.R., Mohrenweiser, H.W. & Bell, D.A. (2001) Genetic variability in susceptibility and response to toxicants. Toxicology Letters, 120, 269280.
  • Mohrenweiser, H.W. & Jones, I.M. (1998) Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation? Mutation Research, 400, 1524.
  • Tuimala, J., Szekely, G., Gundy, S., Hirvonen, A. & Norppa, H. (2002) Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis, 23, 10031008.
  • De Wind, N., Dekker, M., Berns, A., Radman, M. & Te Riele, H. (1995) Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell, 82, 321330.